Obesity & Metabolic Weight Management
About This Condition
Obesity is a chronic, relapsing neuroendocrine disease — not a failure of willpower. It is driven by complex interactions between genetics, hormonal signaling (leptin resistance, insulin resistance, ghrelin dysregulation), gut microbiome composition, sleep, stress physiology, and environmental factors. Despite this, most medical care offers little beyond "eat less, move more" and, increasingly, a prescription for a GLP-1 agonist without a surrounding metabolic framework. The result is patients who lose weight initially but regain it, often with higher body fat percentage and reduced lean muscle mass — a phenomenon called sarcopenic obesity.
.png)





.png)



